The use of 5-FU, mitomycin-C or oxaliplatin leads to higher expression of epithelial cell adhesion molecule (EpCAM) and LeY antigen, which is a blood group antigen with a potent expression on the surface of epithelial tumors, including small cell lung cancer (13, 82). The gene discussed is EPCAM; the disease is small cell lung carcinoma.